Marina Khalil1, Niamh Power1, Eva Graham2, Sonya S Deschênes3, Norbert Schmitz4. 1. Department of Psychiatry, Faculty of Medicine, McGill University, Montreal, QC, Canada; Douglas Research Centre, Montreal, QC, Canada. 2. Douglas Research Centre, Montreal, QC, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, Faculty of Medicine, McGill University, Montreal, QC, Canada. 3. Department of Psychiatry, Faculty of Medicine, McGill University, Montreal, QC, Canada; Douglas Research Centre, Montreal, QC, Canada; School of Psychology, University College Dublin, Dublin, Ireland. 4. Department of Psychiatry, Faculty of Medicine, McGill University, Montreal, QC, Canada; Douglas Research Centre, Montreal, QC, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, Faculty of Medicine, McGill University, Montreal, QC, Canada; Montreal Diabetes Research Centre, Montreal, QC, Canada. Electronic address: norbert.schmitz@mcgill.ca.
Abstract
AIM: This study aimed to systematically review the prevalence of diagnosed sleep disorders in people with diabetes and to determine the association between sleep disorders and blood glucose levels and diabetes outcomes. METHODS: We conducted a literature search in the following databases: MEDLINE (Pubmed), EMBASE, CINAHL, PsychInfo and Web of Science Citation Index. Meta-analysis (random-effects models) was conducted to estimate the prevalence of sleep disorders in people with diabetes. RESULTS: Forty-one articles measured the prevalence of sleep disorders in adults with diabetes. The estimated pooled prevalence of sleep disorders in diabetes was estimated to be 52% (95% CI 42-63%). The highest pooled prevalence was observed for unspecified sleep apnea (69%; 95% CI: 59-78%), followed by obstructive sleep apnea (60%; 95% CI 39-80%), and restless leg syndrome (27%; 95% CI 20-34%). Eleven studies examined the association between sleep disorders and diabetes control and complications. The presence of comorbid sleep disorders was associated with increased diabetes outcomes. CONCLUSIONS: Diagnosed sleep disorders are highly prevalent in people with diabetes. Sleep disorders are associated with diabetes outcomes, though there was considerable heterogeneity across studies.
AIM: This study aimed to systematically review the prevalence of diagnosed sleep disorders in people with diabetes and to determine the association between sleep disorders and blood glucose levels and diabetes outcomes. METHODS: We conducted a literature search in the following databases: MEDLINE (Pubmed), EMBASE, CINAHL, PsychInfo and Web of Science Citation Index. Meta-analysis (random-effects models) was conducted to estimate the prevalence of sleep disorders in people with diabetes. RESULTS: Forty-one articles measured the prevalence of sleep disorders in adults with diabetes. The estimated pooled prevalence of sleep disorders in diabetes was estimated to be 52% (95% CI 42-63%). The highest pooled prevalence was observed for unspecifiedsleep apnea (69%; 95% CI: 59-78%), followed by obstructive sleep apnea (60%; 95% CI 39-80%), and restless leg syndrome (27%; 95% CI 20-34%). Eleven studies examined the association between sleep disorders and diabetes control and complications. The presence of comorbid sleep disorders was associated with increased diabetes outcomes. CONCLUSIONS: Diagnosed sleep disorders are highly prevalent in people with diabetes. Sleep disorders are associated with diabetes outcomes, though there was considerable heterogeneity across studies.
Authors: Bomin Jeon; Faith S Luyster; Susan M Sereika; Monica M DiNardo; Judith A Callan; Eileen R Chasens Journal: J Clin Sleep Med Date: 2022-04-01 Impact factor: 4.062
Authors: Ali Umar; Muhammad Saleem Khan; Sheikh Arslan Sehgal; Kamran Jafar; Shabbir Ahmad; Ahmad Waheed; Muhammad Waseem Aslam; Muhammad Wajid; Tanzil Ur Rehman; Tehmina Khan; Allah Ditta; Hasnain Akmal; Muhammad Ashfaq; Tariq Javed; Rida Tahir Journal: PLoS One Date: 2022-04-21 Impact factor: 3.752
Authors: Cristina Naranjo; María Dueñas; Carlos Barrera; Guillermo Moratalla; Inmaculada Failde Journal: Int J Environ Res Public Health Date: 2020-11-03 Impact factor: 3.390
Authors: Neha A John-Henderson; Benjamin Oosterhoff; Brad Hall; Lester Johnson; Mary Ellen Lafromboise; Melveena Malatare; Emily Salois; Jason R Carter Journal: Sleep Med Date: 2021-07-03 Impact factor: 4.842